[Last word on hormone replacement and breast cancer?].
Rookus M A, van Leeuwen F E, Hamerlynck J V·Nederlands tijdschrift voor geneeskunde
A very large meta-analysis of the Collaborative Group on Hormonal Factors in Breast Cancer has revealed an increasing risk of breast cancer with longer durations of use of hormonal replacement therapy (HRT). This risk increase is restricted to current users of HRT or women who ceased use recently. A 35% increase of the…